- Home
- SWIN vs BNR Comparison
SWIN vs BNR Comparison
Compare SWIN & BNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWIN
- BNR
- Stock Information
- Founded
- SWIN 2017
- BNR 2014
- Country
- SWIN Hong Kong
- BNR China
- Employees
- SWIN N/A
- BNR N/A
- Industry
- SWIN
- BNR Medical Specialities
- Sector
- SWIN
- BNR Health Care
- Exchange
- SWIN Nasdaq
- BNR Nasdaq
- Market Cap
- SWIN 32.1M
- BNR 29.1M
- IPO Year
- SWIN 2023
- BNR 2020
- Fundamental
- Price
- SWIN $3.77
- BNR $3.86
- Analyst Decision
- SWIN
- BNR
- Analyst Count
- SWIN 0
- BNR 0
- Target Price
- SWIN N/A
- BNR N/A
- AVG Volume (30 Days)
- SWIN 238.6K
- BNR 36.5K
- Earning Date
- SWIN 08-21-2025
- BNR 08-21-2025
- Dividend Yield
- SWIN N/A
- BNR N/A
- EPS Growth
- SWIN N/A
- BNR N/A
- EPS
- SWIN N/A
- BNR N/A
- Revenue
- SWIN $3,316,000.00
- BNR $72,112,038.00
- Revenue This Year
- SWIN $29.79
- BNR $136.32
- Revenue Next Year
- SWIN $54.60
- BNR N/A
- P/E Ratio
- SWIN N/A
- BNR N/A
- Revenue Growth
- SWIN N/A
- BNR 0.53
- 52 Week Low
- SWIN $1.16
- BNR $2.18
- 52 Week High
- SWIN $4.40
- BNR $7.90
- Technical
- Relative Strength Index (RSI)
- SWIN 87.26
- BNR 61.98
- Support Level
- SWIN $2.88
- BNR $3.06
- Resistance Level
- SWIN $4.40
- BNR $3.50
- Average True Range (ATR)
- SWIN 0.40
- BNR 0.23
- MACD
- SWIN 0.15
- BNR 0.03
- Stochastic Oscillator
- SWIN 91.70
- BNR 84.78
About SWIN Solowin Holdings
Solowin Holdings Ltd is a investor-focused, versatile securities brokerage company in Hong Kong. It offers a wide spectrum of products and services through its secured one-stop electronic platform. It is engaged in providing securities related services, investment advisory service, and asset management service to customers. The operations were organized into four reportable segments: securities related services, investment advisory services, corporate consultancy services, and asset management services. It derives maximum revenue from investment advisory services.
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.